Skip to main content
Erschienen in: Heart and Vessels 2/2023

29.08.2022 | Original Article

Relationship between early drop in systolic blood pressure, worsening renal function, and in-hospital mortality in patients with heart failure: a retrospective, observational study

verfasst von: Takehiko Kido, Toshitaka Okabe, Shuro Narui, Tatsuki Fujioka, Shigehiro Ishigaki, Soichiro Usumoto, Yu Asukai, Taro Kimura, Suguru Shimazu, Jumpei Saito, Yuji Oyama, Wataru Igawa, Morio Ono, Seitaro Ebara, Myong Hwa Yamamoto, Tadayuki Yakushiji, Naoei Isomura, Masahiko Ochiai

Erschienen in: Heart and Vessels | Ausgabe 2/2023

Einloggen, um Zugang zu erhalten

Abstract

This study aimed to determine the optimal cut-off value of the early drop in systolic blood pressure (SBP) for worsening renal function (WRF) in hospitalized patients with heart failure (HF) and analyze predictors of WRF and the early drop in SBP at that threshold. We retrospectively enrolled 396 patients with acute decompensated HF. The early drop in SBP was defined as the difference between baseline and SBP measured 24 h after hospitalization. We performed receiver operating characteristic (ROC) analysis to determine the optimal cut-off value of the early drop in SBP for WRF and evaluated the effect of the early drop in SBP on in-hospital mortality by multivariate logistic regression analyses. The mean age of the patients was 73.4 ± 14.7 years, and 61.2% were men. A 14.0% drop in SBP was identified as the optimal cut-off value for WRF from the ROC curve analysis. An early drop in SBP ≥ 14.0% was associated with WRF in multivariate logistic regression analysis (odds ratio 7.84; 95% confidence interval 4.06–15.14; P < 0.0001). The dose of intravenous furosemide within 24 h of admission was one of the predictors of the early drop in SBP ≥ 14.0%, while no early drop in SBP was a predictor of in-hospital mortality in multivariate logistic regression models. In conclusion, the optimal cut-off value for WRF in patients with HF was a 14.0% drop in SBP within 24 h of admission. The early drop in SBP ≥ 14.0% was one of the predictors of WRF in patients with HF. However, no early drop in SBP was associated with in-hospital mortality. This study was registered with the University Hospital Medical Information Network in Japan (UMIN000035989).
Literatur
1.
Zurück zum Zitat Forman DE, Butler J, Wang Y, Abraham WT, O’Connor CM, Gottlieb SS, Loh E, Massie BM, Rich MW, Stevenson LW, Young JB (2004) Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 43:61–67CrossRef Forman DE, Butler J, Wang Y, Abraham WT, O’Connor CM, Gottlieb SS, Loh E, Massie BM, Rich MW, Stevenson LW, Young JB (2004) Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 43:61–67CrossRef
2.
Zurück zum Zitat Okabe T, Yakushiji T, Kido T, Oyama Y, Igawa W, Ono M, Ebara S, Yamashita K, Yamamoto MH, Saito S, Amemiya K (2017) Relationship between worsening renal function and long-term cardiovascular mortality in heart failure patients. Int J Cardiol 230:47–52CrossRef Okabe T, Yakushiji T, Kido T, Oyama Y, Igawa W, Ono M, Ebara S, Yamashita K, Yamamoto MH, Saito S, Amemiya K (2017) Relationship between worsening renal function and long-term cardiovascular mortality in heart failure patients. Int J Cardiol 230:47–52CrossRef
3.
Zurück zum Zitat Metra M, Nodari S, Parrinello G, Bordonali T, Bugatti S, Danesi R, Fontanella B, Lombardi C, Milani P, Verzura G, Cotter G (2008) Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. Eur J Heart Fail 10:188–195CrossRef Metra M, Nodari S, Parrinello G, Bordonali T, Bugatti S, Danesi R, Fontanella B, Lombardi C, Milani P, Verzura G, Cotter G (2008) Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. Eur J Heart Fail 10:188–195CrossRef
4.
Zurück zum Zitat Testani JM, Chen J, McCauley BD, Kimmel SE, Shannon RP (2010) Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation 122:265–272CrossRef Testani JM, Chen J, McCauley BD, Kimmel SE, Shannon RP (2010) Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation 122:265–272CrossRef
5.
Zurück zum Zitat Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC, Young JB, Tang WW (2009) Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 53:589–596CrossRef Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC, Young JB, Tang WW (2009) Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 53:589–596CrossRef
6.
Zurück zum Zitat Voors AA, Davison BA, Felker GM, Ponikowski P, Unemori E, Cotter G, Teerlink JR, Greenberg BH, Filippatos G, Teichman SL, Metra M (2011) Early drop in systolic blood pressure and worsening renal function in acute heart failure: renal results of Pre-RELAX-AHF. Eur J Heart Fail 13:961–967CrossRef Voors AA, Davison BA, Felker GM, Ponikowski P, Unemori E, Cotter G, Teerlink JR, Greenberg BH, Filippatos G, Teichman SL, Metra M (2011) Early drop in systolic blood pressure and worsening renal function in acute heart failure: renal results of Pre-RELAX-AHF. Eur J Heart Fail 13:961–967CrossRef
7.
Zurück zum Zitat Cotter G, Metra M, Davison BA, Jondeau G, Cleland JG, Bourge RC, Milo O, O’Connor CM, Parker JD, Torre-Amione G, van Veldhuisen DJ (2018) Systolic blood pressure reduction during the first 24 h in acute heart failure admission: friend or foe? Eur J Heart Fail 20:317–322CrossRef Cotter G, Metra M, Davison BA, Jondeau G, Cleland JG, Bourge RC, Milo O, O’Connor CM, Parker JD, Torre-Amione G, van Veldhuisen DJ (2018) Systolic blood pressure reduction during the first 24 h in acute heart failure admission: friend or foe? Eur J Heart Fail 20:317–322CrossRef
8.
Zurück zum Zitat Testani JM, Coca SG, McCauley BD, Shannon RP, Kimmel SE (2011) Impact of changes in blood pressure during the treatment of acute decompensated heart failure on renal and clinical outcomes. Eur J Heart Fail 13:877–884CrossRef Testani JM, Coca SG, McCauley BD, Shannon RP, Kimmel SE (2011) Impact of changes in blood pressure during the treatment of acute decompensated heart failure on renal and clinical outcomes. Eur J Heart Fail 13:877–884CrossRef
9.
Zurück zum Zitat McKee PA, Castelli WP, McNamara PM, Kannel WB (1971) The natural history of congestive heart failure: the Framingham study. N Engl J Med 285:1441–1446CrossRef McKee PA, Castelli WP, McNamara PM, Kannel WB (1971) The natural history of congestive heart failure: the Framingham study. N Engl J Med 285:1441–1446CrossRef
10.
Zurück zum Zitat McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JG (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42:3599–3726CrossRef McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JG (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42:3599–3726CrossRef
11.
Zurück zum Zitat Okabe T, Yakushiji T, Kido T, Kimura T, Asukai Y, Shimazu S, Saito J, Oyama Y, Igawa W, Ono M, Ebara S (2020) Poor prognosis of heart failure patients with in-hospital worsening renal function and elevated BNP at discharge. ESC Heart Fail 7:2912–2921CrossRef Okabe T, Yakushiji T, Kido T, Kimura T, Asukai Y, Shimazu S, Saito J, Oyama Y, Igawa W, Ono M, Ebara S (2020) Poor prognosis of heart failure patients with in-hospital worsening renal function and elevated BNP at discharge. ESC Heart Fail 7:2912–2921CrossRef
12.
Zurück zum Zitat Dupont M, Mullens W, Finucan M, Taylor DO, Starling RC, Tang WW (2013) Determinants of dynamic changes in serum creatinine in acute decompensated heart failure: the importance of blood pressure reduction during treatment. Eur J Heart Fail 15:433–440CrossRef Dupont M, Mullens W, Finucan M, Taylor DO, Starling RC, Tang WW (2013) Determinants of dynamic changes in serum creatinine in acute decompensated heart failure: the importance of blood pressure reduction during treatment. Eur J Heart Fail 15:433–440CrossRef
13.
Zurück zum Zitat Nelson GI, Silke B, Ahuja RC, Hussain M, Taylor SH (1983) Haemodynamic advantages of isosorbide dinitrate over frusemide in acute heart-failure following myocardial infarction. Lancet 1:730–733CrossRef Nelson GI, Silke B, Ahuja RC, Hussain M, Taylor SH (1983) Haemodynamic advantages of isosorbide dinitrate over frusemide in acute heart-failure following myocardial infarction. Lancet 1:730–733CrossRef
14.
Zurück zum Zitat Hasin T, Zalut T, Hasin Y (2018) Managing the patient with heart failure in the emergency department. Eur Heart J 39:3493–3495CrossRef Hasin T, Zalut T, Hasin Y (2018) Managing the patient with heart failure in the emergency department. Eur Heart J 39:3493–3495CrossRef
15.
Zurück zum Zitat Thooft A, Favory R, Salgado DR, Taccone FS, Donadello K, De Backer D, Creteur J, Vincent JL (2011) Effects of changes in arterial pressure on organ perfusion during septic shock. Crit Care 15:R222CrossRef Thooft A, Favory R, Salgado DR, Taccone FS, Donadello K, De Backer D, Creteur J, Vincent JL (2011) Effects of changes in arterial pressure on organ perfusion during septic shock. Crit Care 15:R222CrossRef
16.
Zurück zum Zitat Patel PA, Heizer G, O’Connor CM, Schulte PJ, Dickstein K, Ezekowitz JA, Armstrong PW, Hasselblad V, Mills RM, McMurray JJ, Starling RC (2014) Hypotension during hospitalization for acute heart failure is independently associated with 30-day mortality: findings from ASCEND-HF. Circ Heart Fail 7:918–925CrossRef Patel PA, Heizer G, O’Connor CM, Schulte PJ, Dickstein K, Ezekowitz JA, Armstrong PW, Hasselblad V, Mills RM, McMurray JJ, Starling RC (2014) Hypotension during hospitalization for acute heart failure is independently associated with 30-day mortality: findings from ASCEND-HF. Circ Heart Fail 7:918–925CrossRef
17.
Zurück zum Zitat DeVore AD, Hammill BG, Sharma PP, Qualls LG, Mentz RJ, Waltman Johnson K, Fonarow GC, Curtis LH, Hernandez AF (2014) In-hospital worsening heart failure and associations with mortality, readmission, and healthcare utilization. J Am Heart Assoc 3:e001088CrossRef DeVore AD, Hammill BG, Sharma PP, Qualls LG, Mentz RJ, Waltman Johnson K, Fonarow GC, Curtis LH, Hernandez AF (2014) In-hospital worsening heart failure and associations with mortality, readmission, and healthcare utilization. J Am Heart Assoc 3:e001088CrossRef
18.
Zurück zum Zitat AlFaleh H, Elasfar AA, Ullah A, AlHabib KF, Hersi A, Mimish L, Almasood A, Al Ghamdi S, Ghabashi A, Malik A, Hussein GA (2017) Worsening heart failure in ‘real-world’ clinical practice: predictors and prognostic impact. Eur J Heart Fail 19:987–995CrossRef AlFaleh H, Elasfar AA, Ullah A, AlHabib KF, Hersi A, Mimish L, Almasood A, Al Ghamdi S, Ghabashi A, Malik A, Hussein GA (2017) Worsening heart failure in ‘real-world’ clinical practice: predictors and prognostic impact. Eur J Heart Fail 19:987–995CrossRef
19.
Zurück zum Zitat Costello-Boerrigter LC, Smith WB, Boerrigter G, Ouyang J, Zimmer CA, Orlandi C, Burnett JC Jr (2006) Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure. Am J Physiol Ren Physiol 290:F273–F278CrossRef Costello-Boerrigter LC, Smith WB, Boerrigter G, Ouyang J, Zimmer CA, Orlandi C, Burnett JC Jr (2006) Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure. Am J Physiol Ren Physiol 290:F273–F278CrossRef
20.
Zurück zum Zitat Matsue Y, Suzuki M, Seya M, Iwatsuka R, Mizukami A, Nagahori W, Ohno M, Matsumura A, Hashimoto Y (2013) Tolvaptan reduces the risk of worsening renal function in patients with acute decompensated heart failure in high-risk population. J Cardiol 61:169–174CrossRef Matsue Y, Suzuki M, Seya M, Iwatsuka R, Mizukami A, Nagahori W, Ohno M, Matsumura A, Hashimoto Y (2013) Tolvaptan reduces the risk of worsening renal function in patients with acute decompensated heart failure in high-risk population. J Cardiol 61:169–174CrossRef
21.
Zurück zum Zitat Inomata T, Ikeda Y, Kida K, Shibagaki Y, Sato N, Kumagai Y, Shinagawa H, Ako J, Izumi T, Investigators KA (2017) Effects of additive tolvaptan vs. increased furosemide on heart failure with diuretic resistance and renal impairment- results from the K-STAR study. Circ J 82:159–167CrossRef Inomata T, Ikeda Y, Kida K, Shibagaki Y, Sato N, Kumagai Y, Shinagawa H, Ako J, Izumi T, Investigators KA (2017) Effects of additive tolvaptan vs. increased furosemide on heart failure with diuretic resistance and renal impairment- results from the K-STAR study. Circ J 82:159–167CrossRef
22.
Zurück zum Zitat Kimura K, Momose T, Hasegawa T, Morita T, Misawa T, Motoki H, Izawa A, Ikeda U (2016) Early administration of tolvaptan preserves renal function in elderly patients with acute decompensated heart failure. J Cardiol 67:399–405CrossRef Kimura K, Momose T, Hasegawa T, Morita T, Misawa T, Motoki H, Izawa A, Ikeda U (2016) Early administration of tolvaptan preserves renal function in elderly patients with acute decompensated heart failure. J Cardiol 67:399–405CrossRef
23.
Zurück zum Zitat Matsue Y, Ter Maaten JM, Suzuki M, Torii S, Yamaguchi S, Fukamizu S, Ono Y, Fujii H, Kitai T, Nishioka T, Sugi K (2017) Early treatment with tolvaptan improves diuretic response in acute heart failure with renal dysfunction. Clin Res Cardiol 106:802–812CrossRef Matsue Y, Ter Maaten JM, Suzuki M, Torii S, Yamaguchi S, Fukamizu S, Ono Y, Fujii H, Kitai T, Nishioka T, Sugi K (2017) Early treatment with tolvaptan improves diuretic response in acute heart failure with renal dysfunction. Clin Res Cardiol 106:802–812CrossRef
24.
Zurück zum Zitat Matsue Y, Damman K, Voors AA, Kagiyama N, Yamaguchi T, Kuroda S, Okumura T, Kida K, Mizuno A, Oishi S, Inuzuka Y (2017) Time-to-furosemide treatment and mortality in patients hospitalized with acute heart failure. J Am Coll Cardiol 69:3042–3051CrossRef Matsue Y, Damman K, Voors AA, Kagiyama N, Yamaguchi T, Kuroda S, Okumura T, Kida K, Mizuno A, Oishi S, Inuzuka Y (2017) Time-to-furosemide treatment and mortality in patients hospitalized with acute heart failure. J Am Coll Cardiol 69:3042–3051CrossRef
25.
Zurück zum Zitat Nelson GI, Silke B, Forsyth DR, Verma SP, Hussain M, Taylor SH (1983) Hemodynamic comparison of primary venous or arteriolar dilatation and the subsequent effect of furosemide in left ventricular failure after acute myocardial infarction. Am J Cardiol 52:1036–1040CrossRef Nelson GI, Silke B, Forsyth DR, Verma SP, Hussain M, Taylor SH (1983) Hemodynamic comparison of primary venous or arteriolar dilatation and the subsequent effect of furosemide in left ventricular failure after acute myocardial infarction. Am J Cardiol 52:1036–1040CrossRef
26.
Zurück zum Zitat Gheorghiade M, Abraham WT, Albert NM, Greenberg BH, O’Connor CM, She L, Stough WG, Yancy CW, Young JB, Fonarow GC, OPTIMIZE-HF investigators and coordinators, (2006) Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA 296:2217–2226CrossRef Gheorghiade M, Abraham WT, Albert NM, Greenberg BH, O’Connor CM, She L, Stough WG, Yancy CW, Young JB, Fonarow GC, OPTIMIZE-HF investigators and coordinators, (2006) Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA 296:2217–2226CrossRef
Metadaten
Titel
Relationship between early drop in systolic blood pressure, worsening renal function, and in-hospital mortality in patients with heart failure: a retrospective, observational study
verfasst von
Takehiko Kido
Toshitaka Okabe
Shuro Narui
Tatsuki Fujioka
Shigehiro Ishigaki
Soichiro Usumoto
Yu Asukai
Taro Kimura
Suguru Shimazu
Jumpei Saito
Yuji Oyama
Wataru Igawa
Morio Ono
Seitaro Ebara
Myong Hwa Yamamoto
Tadayuki Yakushiji
Naoei Isomura
Masahiko Ochiai
Publikationsdatum
29.08.2022
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 2/2023
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-022-02160-6

Weitere Artikel der Ausgabe 2/2023

Heart and Vessels 2/2023 Zur Ausgabe

Neu im Fachgebiet Kardiologie

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.